Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Biome Australia Ltd ( (AU:BIO) ) just unveiled an announcement.
Biome Australia Limited reported a strong third quarter for fiscal year 2025, with sales revenue reaching approximately $4.5 million, marking a 41% increase compared to the same period last year. The company has achieved a compounded annual growth rate of 70% over the past three years and has been recognized as the retail supplier of the year by Terry White Chemmart, Australia’s largest pharmacy group. This recognition and the significant sales growth highlight Biome’s successful market positioning and operational strategy, setting a positive outlook for the remainder of the fiscal year.
More about Biome Australia Ltd
Biome Australia Limited is a microbiome health company that focuses on developing products and services to enhance gut health. The company is listed on the Australian Securities Exchange (ASX) under the ticker BIO.
YTD Price Performance: -16.95%
Average Trading Volume: 459,093
Technical Sentiment Signal: Sell
Learn more about BIO stock on TipRanks’ Stock Analysis page.